Cargando…
Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance
SIMPLE SUMMARY: Bevacizumab mediated anti-angiogenesis provides a new chance of survival for patients with a tumor. However, most patients have acquired bevacizumab resistance after continuous treatment, and there is no available clinical therapy to overcome drug resistance. In this study, we analyz...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688485/ https://www.ncbi.nlm.nih.gov/pubmed/36428773 http://dx.doi.org/10.3390/cancers14225681 |